olmesartan has been researched along with Emesis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gonakoti, S; Khullar, S; Rajkumar, A | 1 |
| Arnason, T; Igoe, J; Kulai, T; MacIntosh, D | 1 |
| Herman, ML; Kelly, DG; Ludvigsson, JF; Mangan, TF; Murray, JA; Rubio-Tapia, A; Wu, TT | 1 |
1 review(s) available for olmesartan and Emesis
| Article | Year |
|---|---|
Duodenal Villous Atrophy in a TTG-Negative Patient Taking Olmesartan: A Case Report and Review of the Literature.
Topics: Aged; Antihypertensive Agents; Atrophy; Biopsy; Collagenous Sprue; Diarrhea; Duodenum; Humans; Hypertension; Imidazoles; Male; Tetrazoles; Vomiting; Weight Loss | 2016 |
2 other study(ies) available for olmesartan and Emesis
| Article | Year |
|---|---|
Olmesartan Associated Enteropathy: A Rare Underdiagnosed Cause of Diarrhea and Weight Loss.
Topics: Antihypertensive Agents; Colitis, Lymphocytic; Diarrhea; Humans; Imidazoles; Male; Middle Aged; Tetrazoles; Vomiting; Weight Loss | 2019 |
Severe spruelike enteropathy associated with olmesartan.
Topics: Abdominal Pain; Aged; Aged, 80 and over; Anemia; Angiotensin II Type 1 Receptor Blockers; Atrophy; Biopsy; Colitis, Microscopic; Collagen; Diarrhea; Fatigue; Female; Gastritis; Hospitalization; Humans; Hypoalbuminemia; Imidazoles; Inflammation; Intestinal Mucosa; Intestines; Lymphocytes; Male; Middle Aged; Nausea; Severity of Illness Index; Stomach; Tetrazoles; Vomiting; Water-Electrolyte Imbalance; Weight Loss; Zinc | 2012 |